4884.T
Price:
$392
Market Cap:
$2.68B
Kringle Pharma, Inc. engages in the research and development, manufactures, and sells hepatocyte growth factor (HGF) protein pharmaceuticals for regenerative medicines. The company develops HGF products for the treatment of acute spinal cord injury, amyotrophic lateral sclerosis, vocal fold scar, and acute kidney injury. Kringle Pharma, Inc. was incorporated in 2001 and is based in Ibaraki, Japan.
Industry
Biotechnology
IPO Date
2020-12-28
Stock Exchange
JPX
Ticker
4884.T
According to Kringle Pharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.05B. This represents a change of -74.27% compared to the average of 4.07B of the last 4 quarters.
The mean historical Enterprise Value of Kringle Pharma, Inc. over the last ten years is 2.36B. The current 1.05B Enterprise Value has changed 4.33% with respect to the historical average. Over the past ten years (40 quarters), 4884.T's Enterprise Value was at its highest in in the March 2025 quarter at 4.71B. The Enterprise Value was at its lowest in in the September 2022 quarter at -134477650.00.
Average
2.36B
Median
2.55B
Minimum
-570827000.00
Maximum
4.92B
Discovering the peaks and valleys of Kringle Pharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 43.53%
Maximum Annual Enterprise Value = 4.92B
Minimum Annual Increase = -479.26%
Minimum Annual Enterprise Value = -570827000.00
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 3.11B | 43.53% |
| 2023 | 2.16B | -479.26% |
| 2022 | -570827000.00 | -135.02% |
| 2021 | 1.63B | -44.54% |
| 2020 | 2.94B | -40.26% |
The current Enterprise Value of Kringle Pharma, Inc. (4884.T) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.57B
5-year avg
1.85B
10-year avg
2.36B
Kringle Pharma, Inc.’s Enterprise Value is less than Trans Genic Inc. (5.26B), less than Kubota Pharmaceutical Holdings Co., Ltd. (1.89B), less than FunPep Company Limited (1.16B), less than PhoenixBio Co., Ltd. (1.65B), less than Ribomic Inc. (1.93B), less than Carna Biosciences, Inc. (3.56B), less than Care Service Co.,Ltd. (1.18B), less than Miahelsa Holdings Corporation (3.93B), less than Welby Inc. (1.98B), less than Platz Co., Ltd. (3.19B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 5.26B | $4.71B | |
| 1.89B | $3.00B | |
| 1.16B | $3.49B | |
| 1.65B | $2.19B | |
| 1.93B | $3.64B | |
| 3.56B | $4.60B | |
| 1.18B | $3.01B | |
| 3.93B | $3.16B | |
| 1.98B | $2.32B | |
| 3.19B | $2.79B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kringle Pharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Kringle Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Kringle Pharma, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Kringle Pharma, Inc. (4884.T)?
What is the 3-year average Enterprise Value for Kringle Pharma, Inc. (4884.T)?
What is the 5-year average Enterprise Value for Kringle Pharma, Inc. (4884.T)?
How does the current Enterprise Value for Kringle Pharma, Inc. (4884.T) compare to its historical average?